A study conducted by Chung et al. [41], using ovarian teratoma cells, provided evidence that ligand-independent AR functions in cancer stem/progenitor cells (CD133+ cells) facilitated ovarian teratoma cell growth. The gene discussed is PROM1; the disease is cancer.